Navigation Links
Defeat Autism Now!(R) Regional Conference to be Held in Oklahoma June 13-14, 2009
Date:4/14/2009

NORMAN, Okla., April 14 /PRNewswire/ -- Aaron's Bridge presents Autism Research Institute's Defeat Autism Now!(R) Regional Conference June 13-14, 2009, at The Embassy Suites Hotel and Convention Center at 2501 Conference Drive in Norman. The conference will feature seminars devoted to educating doctors, parents and professionals. Presenters including Elizabeth Mumper, MD; Bryan Jepson, MD; Dan Rossignol, MD; and Doreen Granpeesheh, PhD, will discuss topics such as behavioral and biomedical strategies, dietary interventions, what parents can do now and hands-on workshops for implementing treatment strategies.

On June 14, a Clinician Introductory Workshop with CME Credits will cover topics such as case histories, medical treatment strategies for gut disease and autism, integration of science and biomedical interventions for autism. A complimentary lunch will be provided by Aaron's Bridge.

"Autism is a challenge for pediatricians, their patients and families. By working together, we stand the best chance of helping these children to realize their full potential," American Academy of Pediatrics President Renee R. Jenkins, MD, FAAP said this past April. "The Academy is committed to working with researchers and treatment groups like Defeat Autism Now!(R) to get closer to finding answers to the multiple causes of autism and determining effective therapies."

Defeat Autism Now!(R) is distinguished by its commitment to invite only the most credible, accredited and forward-thinking researchers and clinicians as speakers.

The conference is sponsored by Aaron's Bridge. Keith and Joni Geary established Aaron's Bridge foundation because of their personal experience with autism. Their son, Aaron, was diagnosed with autism at age 3, and the family began to see promising improvements in his condition when he began biomedical treatments with Dr. Bryan Jepson at The Thoughtful House Center for Children in Austin, Texas.

Aaron's Bridge was created to facilitate access to more treatment options in Oklahoma for children with developmental disabilities, including autism spectrum disorder.

"We formed the foundation to build a bridge of hope, connecting Oklahoma families to effective solutions and treatment options, such as biomedical interventions," Joni Geary said. "This conference will provide families, particularly Oklahoma families, with up-to-date information regarding effective treatments for autism and most importantly, hope."

For a complete schedule and to register, go to www.regonline.com/ari-oklahoma.


'/>"/>
SOURCE Aaron?s Bridge
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
2. First Annual Autism Conference at Packard Childrens and Stanford Brings Parents and Researchers Together
3. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
4. A Magnetic Gift: Sumter Regional Hospital Receives New MRI as Charitable Donation From Siemens
5. onTargetjobs Announces Acquisition of RegionalHelpWanted.com
6. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
7. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
8. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. China Biopharma Reaches Agreement with a Regional Pharma to Launch New Pharmaceutical Products
10. New Regional Biotech Association Formed
11. Shasta Regional Medical Center Awarded Full Accreditation from the Joint Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ... an interactive FDA compliance training course, Writing Effective SOPs ... accredited interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step ...
(Date:2/4/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... Edward Lanphier , Sangamo,s president and chief executive ... Sangamo,s ZFP Therapeutic ® development programs and an ... ET on Thursday, February 11, 2016, at the Leerink ... conference is being held in New York ...
Breaking Biology Technology:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
Breaking Biology News(10 mins):